Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.
Blood|February 1, 1992
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusionM L Grossbard, A S Freedman, J Ritz, et al.
British Journal of Haematology|August 8, 1998
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myelomaM L Grossbard, P Fidias, J Kinsella, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II studyC D Wright, J C Wain, T J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasmsM L Grossbard, J M Lambert, V S Goldmacher, et al.
The New England Journal of Medicine|November 28, 1991
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphomaJ G Gribben, A S Freedman, D Neuberg, et al.
Seminars in Oncology|November 24, 1999
Treatment of plasma cell dyscrasias by antibody-mediated immunotherapyS P Treon, Y Shima, F I Preffer, et al.
Seminars in Oncology|August 1, 1995
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancerG M Strauss, T J Lynch, A D Elias, et al.
Blood|May 1, 1993
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphomaM L Grossbard, J G Gribben, A S Freedman, et al.
Pageof 4